Syros Pharmaceuticals, Inc.
Compositions of cyclin dependent kinase 7 (CDK7) inhibitor

Abstract:

The present invention provides, in part, compositions comprising an inhibitor of cyclin-dependent kinase 7 (CDK7) and sulfobutyl ether-.beta.-cyclodextrin. Also provided are methods of using a disclosed composition for treating proliferative diseases. The present invention also provides methods of making disclosed compositions.